Founded 17 years ago, Gêniris is a well established patient organisation active in many healthcare and research institutions. The representative Marjorie Poeydomenge described its activities during the Aniridia Europe Community Meeting in Alicante, on the 3rd of June 2022.

Among Gêniris’ most noticeable achievements, the French guidelines for congenital aniridia and WAGR syndrome and the TEP, the world’s first therapeutic education program for patients with congenital aniridia. Discover more here.